Norlase
PrivateLast Round
Debt
Feb 27, 2025
Est. Valuation
$60M
Total Funding Raised
$14.07M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Norlase is a medical device company that develops and manufactures next-generation laser solutions for the treatment of retina and glaucoma diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Norlase Comparables
Compare Norlase with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OD-OS GmbH | 81% | |
| Lumibird | 80% | |
| IRIDEX Corporation | 78% | |
Norlase Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 27, 2025 | ||||
| VC Round | May 23, 2023 | ||||
| Series B | Oct 25, 2021 | ||||
| Series A | Mar 1, 2019 | ||||
| Grant | Dec 17, 2014 |
Key People
Founding team and executive leadership
Norlase Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| European Investment Bank Group | Debt |
| West Hill Capital | Series A, Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 34% MoM, reaching 10.7K.
- May 16, 2026
Monthly visitors increased 88% MoM, reaching 16.4K.
Norlase Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Norlase's valuation, stock price, and market status.